- Home
- CNTA vs AVNT Comparison
CNTA vs AVNT Comparison
Compare CNTA & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | AVNT |
|---|---|---|
| Founded | 2020 | 1927 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 3.4B |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CNTA | AVNT |
|---|---|---|
| Price | $39.45 | $36.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $43.17 | $41.50 |
| AVG Volume (30 Days) | ★ 4.9M | 466.5K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.98% |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ 0.89 |
| Revenue | $15,000,000.00 | ★ $3,835,500,000.00 |
| Revenue This Year | N/A | $4.90 |
| Revenue Next Year | N/A | $3.48 |
| P/E Ratio | ★ N/A | $41.36 |
| Revenue Growth | N/A | ★ 1.71 |
| 52 Week Low | $10.95 | $27.48 |
| 52 Week High | $40.26 | $44.85 |
Technical Indicators
Market Signals| Indicator | CNTA | AVNT |
|---|---|---|
| Relative Strength Index (RSI) | 73.18 | 44.19 |
| Support Level | $39.16 | $35.07 |
| Resistance Level | $40.26 | $38.10 |
| Average True Range (ATR) | 0.20 | 1.02 |
| MACD | -0.47 | -0.12 |
| Stochastic Oscillator | 47.54 | 6.57 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About AVNT Avient Corporation
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.